Highlights and Quick Summary
- Net Debt for the quarter ending May 31, 2022 was $-94.3 Million (a -16.19% decrease compared to previous quarter)
- Year-over-year quarterly Net Debt decreased by -33.1%
- Annual Net Debt for 2021 was $-141 Million (a -517.37% decrease from previous year)
- Annual Net Debt for 2020 was $33.8 Million (a 2637.26% increase from previous year)
- Annual Net Debt for 2019 was $1.23 Million (a -105.19% decrease from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Debt of Organigram Holdings Inc.
Most recent Net Debtof OGI including historical data for past 10 years.Interactive Chart of Net Debt of Organigram Holdings Inc.
Organigram Holdings Inc. Net Debt for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $-94.31 | $-112.52 | – | – | – |
| 2021 | $-124.98 | $-140.96 | $-157.23 | $-9.66 | $-140.96 |
| 2020 | $-14.11 | $30.16 | $29.1 | $33.37 | $33.77 |
| 2019 | $38.1 | $1.24 | $-28.56 | $-0.81 | $1.23 |
| 2018 | – | – | $2.12 | $-24.2 | $-23.77 |
| 2017 | – | – | – | – | $-23.97 |
| 2016 | – | – | – | – | $-19.19 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic